Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]
Terao T, Ishida A, Kimura T, Yoshida M, Hara T. Neuropsychiatr Dis Treat. 2017;13:1441–1448.On page 1443, Results section, Patient disposition subheading, Figure S1, ‘Excluded from HAM-D analysis setC 69’ should have been ‘Excluded from HAM-D analysis setC 269...
Guardado en:
Autores principales: | Terao T, Ishida A, Kimura T, Yoshida M, Hara T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d12b18d138da44868132c01afdf4ec31 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report
por: Terao T, et al.
Publicado: (2017) -
Long-term efficacy and safety of lamotrigine for all types of bipolar disorder
por: Watanabe Y, et al.
Publicado: (2017) -
Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients
por: Barbara Błaszczyk, et al.
Publicado: (2010) -
A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder
por: Tränkner A, et al.
Publicado: (2013) -
Safety and effectiveness of controlled-release paroxetine in routine clinical practice: results of a postmarketing surveillance study of patients with depression
por: Kato M, et al.
Publicado: (2015)